AD

Ledipasvir(CAS: 1256388-51-8)

Ledipasvir
CAS Number

Related Products

Other Suppliers for Ledipasvir

Basic Information

Molecular Formula
C49H54F2N8O6
Molecular Weight
889.02 g/mol

Chemical Identifiers

SMILES
CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC
InChIKey
VRTWBAAJJOHBQU-KMWAZVGDSA-N

Database References

MDL Number
MFCD25976756

FAQ

Ledipasvir (CAS: 1256388-51-8) is an antiviral medication classified as a nucleoside analog. It has the chemical formula C21H26N4O6S and is primarily used for treating chronic hepatitis C virus (HCV) infections. The compound is known for its ability to inhibit HCV protease, making it a key component in combination therapies.
Ledipasvir (CAS: 1256388-51-8) is mainly used in pharmaceuticals to treat hepatitis C virus (HCV) infections, often combined with Sofosbuvir. It targets the HCV protease enzyme, preventing viral replication. Its applications also include research for antiviral drug development and potential use in other therapeutic areas.
Ledipasvir (CAS: 1256388-51-8) is generally safe when used as prescribed, but it may cause side effects such as headache, fatigue, or nausea. Safety standards ensure it meets regulatory requirements for pharmaceutical use. Proper handling and protective measures are necessary during storage and administration to minimize risks.
Ledipasvir (CAS: 1256388-51-8) should be stored in a cool, dry place at 20-25°C (68-77°F), away from light. It requires a sealed container to maintain stability and prevent moisture exposure. Avoid freezing and keep it in a secure location to ensure shelf life and efficacy.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

18602735115@163.com